109 related articles for article (PubMed ID: 22705994)
1. Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins.
Weston-Bell NJ; Hendriks D; Sugiyarto G; Bos NA; Kluin-Nelemans HC; Forconi F; Sahota SS
Leukemia; 2013 Jan; 27(1):241-5. PubMed ID: 22705994
[No Abstract] [Full Text] [Related]
2. A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expression.
Simonetti E; Ascani S; Volpetti S; Sabattini E; Falini B; Tiacci E
Br J Haematol; 2018 Dec; 183(5):702. PubMed ID: 30043467
[No Abstract] [Full Text] [Related]
3. Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia.
Ewalt M; Nandula S; Phillips A; Alobeid B; Murty VV; Mansukhani MM; Bhagat G
Hematol Oncol; 2012 Dec; 30(4):190-3. PubMed ID: 22246856
[TBL] [Abstract][Full Text] [Related]
4. Molecular detection of BRAF-V600E is superior to flow cytometry for disease evaluation in hairy cell leukaemia.
Rider T; Powell R; Gover R; Ansell R; Bastow S; Ghurye RR; Stewart H; Chevassut T
Hematol Oncol; 2014 Sep; 32(3):158-61. PubMed ID: 24123063
[No Abstract] [Full Text] [Related]
5. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
Hockley SL; Morilla A; Else M; Dearden C; Catovsky D; Morgan GJ; Matutes E; Gonzalez D
Leukemia; 2010 May; 24(5):1084-6. PubMed ID: 20237507
[No Abstract] [Full Text] [Related]
6. BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia.
Michonneau D; Kaltenbach S; Derrieux C; Trinquand A; Brouzes C; Gibault L; North MO; Delarue R; Varet B; Emile JF; Brousse N; Hermine O
J Clin Oncol; 2014 Dec; 32(35):e117-21. PubMed ID: 24567436
[No Abstract] [Full Text] [Related]
7. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
[TBL] [Abstract][Full Text] [Related]
9. A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?
Schlick K; Troch M; Placher-Sorko G; Faber V; Neureiter D; Berghoff AS; Preusser M; Greil R; Hopfinger G
Ann Hematol; 2015 Feb; 94(2):345-6. PubMed ID: 25055797
[No Abstract] [Full Text] [Related]
10. High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies.
Boyd EM; Bench AJ; van 't Veer MB; Wright P; Bloxham DM; Follows GA; Scott MA
Br J Haematol; 2011 Dec; 155(5):609-12. PubMed ID: 21910720
[TBL] [Abstract][Full Text] [Related]
11. Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes.
Weston-Bell NJ; Forconi F; Kluin-Nelemans HC; Sahota SS
PLoS One; 2014; 9(1):e86556. PubMed ID: 24497953
[TBL] [Abstract][Full Text] [Related]
12. Pyrosequencing of BRAF V600E in routine samples of hairy cell leukaemia identifies CD5+ variant hairy cell leukaemia that lacks V600E.
Lennerz JK; Klaus BM; Marienfeld RB; Möller P
Br J Haematol; 2012 Apr; 157(2):267-9. PubMed ID: 22145942
[No Abstract] [Full Text] [Related]
13. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
Tanami H; Imoto I; Hirasawa A; Yuki Y; Sonoda I; Inoue J; Yasui K; Misawa-Furihata A; Kawakami Y; Inazawa J
Oncogene; 2004 Nov; 23(54):8796-804. PubMed ID: 15467732
[TBL] [Abstract][Full Text] [Related]
14. BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes.
Yap J; Yuan J; Ng WH; Chen GB; Sim YRM; Goh KC; Teo J; Lim TYH; Goay SM; Teo JHJ; Lao Z; Lam P; Sabapathy K; Hu J
Mol Cancer; 2023 Aug; 22(1):125. PubMed ID: 37543582
[TBL] [Abstract][Full Text] [Related]
15. BRAF(V600E) mutation and the biology of papillary thyroid cancer.
Frasca F; Nucera C; Pellegriti G; Gangemi P; Attard M; Stella M; Loda M; Vella V; Giordano C; Trimarchi F; Mazzon E; Belfiore A; Vigneri R
Endocr Relat Cancer; 2008 Mar; 15(1):191-205. PubMed ID: 18310287
[TBL] [Abstract][Full Text] [Related]
16. [Molecular and therapeutic advances in Hairy cell leukemia].
Balsat M; Cornillon J
Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
[TBL] [Abstract][Full Text] [Related]
17. Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia.
Tiacci E; Pucciarini A; Bigerna B; Pettirossi V; Strozzini F; Martelli MP; Tabarrini A; Drexler HG; Falini B
Blood; 2012 May; 119(22):5332-3. PubMed ID: 22653958
[No Abstract] [Full Text] [Related]
18. Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype.
Langabeer SE; O'Brien D; Liptrot S; Flynn CM; Hayden PJ; Conneally E; Browne PV; Vandenberghe E
Int J Lab Hematol; 2012 Aug; 34(4):417-21. PubMed ID: 22313586
[TBL] [Abstract][Full Text] [Related]
19. Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.
Blombery PA; Wong SQ; Hewitt CA; Dobrovic A; Maxwell EL; Juneja S; Grigoriadis G; Westerman DA
Haematologica; 2012 May; 97(5):780-3. PubMed ID: 22133769
[TBL] [Abstract][Full Text] [Related]
20. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
